Lingling Li

Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patiënte...

Selinexor-bortezomib-dexamethason versus bortezomib-dexamethason bij recidief myeloom: BOSTON fase III